The retail clinic market is expected to be valued at US$ 5,659.2 million in 2024 and reach US$ 12,308.7 million by 2034. The market is projected to grow at a CAGR of 8.1% during the forecast period.
Key Market Drivers
Attributes | Key Statistics |
---|---|
Retail Clinic Market Value (2024) | US$ 5,659.2 million |
Anticipated Market Value (2034) | US$ 12,308.7 million |
Value-based CAGR (2024 to 2034) | 8.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The retail clinic market is experiencing substantial growth driven by increasing demand for convenient and accessible healthcare options.
The retail clinic market is anticipated to surpass a valuation of US$ 12,308.7 million by 2034, expanding at an 8.1% CAGR over the forecast period. While the retail clinics market is experiencing growth, several restraining factors can adversely affect its development and expansion:
Attributes | Details |
---|---|
Ownership Type | Retail-owned |
Market Share in 2024 | 58.6% |
Based on the ownership type, the retail-owned segment dominates the market with a share of 58.6% in 2024. The segment’s rising popularity is attributed to the following factors:
Attributes | Details |
---|---|
Distribution Channel | Drug Store |
Market Share | 52.0% |
Based on the distribution channel, drug stores dominate the market by distribution channel, holding a share of 52.0%. This rising popularity of the segment is attributed to the following reasons:
The section analyzes the retail clinic market by country, including the United States, China, Germany, France, and Japan. The table presents the CAGRs for each country, indicating the expected market growth in that country through 2034.
Countries | CAGR (2024 to 2034) |
---|---|
United States | 10.9% |
China | 11.4% |
Germany | 10.6% |
France | 10.2% |
Japan | 10.3% |
China is a leading Asian country in the retail clinic market. The Chinese market is anticipated to register a CAGR of 13.6% through 2034.
The United States dominates the retail clinic market in the North American region. The United States retail clinic market is anticipated to exhibit a CAGR of 10.9% through 2034.
In the European region, Germany leads the retail clinic market. Over the coming ten years, the demand for retail clinics in Germany is expected to rise at a 10.6% CAGR.
The Japanese retail clinics market is anticipated to register a CAGR of 10.3% through 2034.
Over the coming ten years, the market in France is expected to rise at a 10.2% CAGR through 2034.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global retail clinic market is highly fragmented, with key players such as Kroger Co., CVS Health, Rite Aid Corp, Walmart Inc., Walgreens Co., and Nextcare Holdings, Inc. dominating the landscape.
By embedding healthcare services within retail settings, these companies have contributed significantly to the ongoing transformation of healthcare delivery, making essential services more accessible, affordable, and patient-centric for a broader population. Through their strategic location within retail settings, these companies have made accessing healthcare services more convenient, especially for those living in underserved areas. They have also reduced the cost of healthcare services, making them more affordable for the general public.
Recent Developments
The retail clinic market is expected to be worth US$ 5,659.2 million in 2024.
The market for retail clinics is expected to reach US$ 12,308.7 million by 2034.
The retail clinic market is expected to grow at a CAGR of 8.1% from 2024 to 2034.
Some key players in the market are Kroger Co., CVS Health, Rite Aid Corp, Walmart Inc., Walgreens Co., and Nextcare Holdings, Inc.
The drug store segment dominates the market, with a 52.0% share in 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034
5.3.1. Point-of-Care Diagnostics
5.3.2. Clinical Chemistry & Immunoassays
5.3.3. Vaccinations
5.3.4. Others
5.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2024 to 2034
6.3.1. Retail Pharmacy Settings
6.3.2. Drug Stores
6.3.3. Grocery Chains & Big Box Stores
6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Ownership Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Ownership Type , 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Ownership Type , 2024 to 2034
7.3.1. Hospital-owned Retail Clinics
7.3.2. Retail-owned Retail Clinics
7.4. Y-o-Y Growth Trend Analysis By Ownership Type , 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Ownership Type , 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Application
9.2.3. By Distribution Channel
9.2.4. By Ownership Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.3.3. By Distribution Channel
9.3.4. By Ownership Type
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Application
10.2.3. By Distribution Channel
10.2.4. By Ownership Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.3.3. By Distribution Channel
10.3.4. By Ownership Type
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Application
11.2.3. By Distribution Channel
11.2.4. By Ownership Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.3.3. By Distribution Channel
11.3.4. By Ownership Type
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Application
12.2.3. By Distribution Channel
12.2.4. By Ownership Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.3.3. By Distribution Channel
12.3.4. By Ownership Type
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Application
13.2.3. By Distribution Channel
13.2.4. By Ownership Type
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Application
13.3.3. By Distribution Channel
13.3.4. By Ownership Type
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Application
14.2.3. By Distribution Channel
14.2.4. By Ownership Type
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Application
14.3.3. By Distribution Channel
14.3.4. By Ownership Type
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Application
15.2.3. By Distribution Channel
15.2.4. By Ownership Type
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Application
15.3.3. By Distribution Channel
15.3.4. By Ownership Type
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2023
16.1.2.1. By Application
16.1.2.2. By Distribution Channel
16.1.2.3. By Ownership Type
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2023
16.2.2.1. By Application
16.2.2.2. By Distribution Channel
16.2.2.3. By Ownership Type
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2023
16.3.2.1. By Application
16.3.2.2. By Distribution Channel
16.3.2.3. By Ownership Type
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2023
16.4.2.1. By Application
16.4.2.2. By Distribution Channel
16.4.2.3. By Ownership Type
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2023
16.5.2.1. By Application
16.5.2.2. By Distribution Channel
16.5.2.3. By Ownership Type
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2023
16.6.2.1. By Application
16.6.2.2. By Distribution Channel
16.6.2.3. By Ownership Type
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2023
16.7.2.1. By Application
16.7.2.2. By Distribution Channel
16.7.2.3. By Ownership Type
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2023
16.8.2.1. By Application
16.8.2.2. By Distribution Channel
16.8.2.3. By Ownership Type
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2023
16.9.2.1. By Application
16.9.2.2. By Distribution Channel
16.9.2.3. By Ownership Type
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2023
16.10.2.1. By Application
16.10.2.2. By Distribution Channel
16.10.2.3. By Ownership Type
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2023
16.11.2.1. By Application
16.11.2.2. By Distribution Channel
16.11.2.3. By Ownership Type
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2023
16.12.2.1. By Application
16.12.2.2. By Distribution Channel
16.12.2.3. By Ownership Type
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2023
16.13.2.1. By Application
16.13.2.2. By Distribution Channel
16.13.2.3. By Ownership Type
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2023
16.14.2.1. By Application
16.14.2.2. By Distribution Channel
16.14.2.3. By Ownership Type
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2023
16.15.2.1. By Application
16.15.2.2. By Distribution Channel
16.15.2.3. By Ownership Type
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2023
16.16.2.1. By Application
16.16.2.2. By Distribution Channel
16.16.2.3. By Ownership Type
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2023
16.17.2.1. By Application
16.17.2.2. By Distribution Channel
16.17.2.3. By Ownership Type
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2023
16.18.2.1. By Application
16.18.2.2. By Distribution Channel
16.18.2.3. By Ownership Type
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2023
16.19.2.1. By Application
16.19.2.2. By Distribution Channel
16.19.2.3. By Ownership Type
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2023
16.20.2.1. By Application
16.20.2.2. By Distribution Channel
16.20.2.3. By Ownership Type
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2023
16.21.2.1. By Application
16.21.2.2. By Distribution Channel
16.21.2.3. By Ownership Type
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2023
16.22.2.1. By Application
16.22.2.2. By Distribution Channel
16.22.2.3. By Ownership Type
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2023
16.23.2.1. By Application
16.23.2.2. By Distribution Channel
16.23.2.3. By Ownership Type
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Application
17.3.3. By Distribution Channel
17.3.4. By Ownership Type
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Access Health
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. AtlantiCare
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Aurora Quick Care
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Target Brands Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Kroger
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Wellness Express
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Walgreens Boots Alliance
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Target Clinic Medical Associates
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. RediClinic
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Now Medical Centers
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports